pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
formula-pharmaceuticals PRESS RELEASE ARCHIVE
Apr 30, 2020
CoImmune, Inc., a US-Based Clinical-Stage Biotech, Completes Merger with Formula Pharmaceuticals, Inc.
Sep 18, 2017
Formula Pharmaceuticals Announces Initiation of the First Clinical Trial for Allogeneic CIK-CAR Cancer Immunotherapy
May 5, 2016
CORRECTING and REPLACING Formula Pharmaceuticals Appoints Malcolm K. Brenner, MD, PhD to Its Scientific Advisory Board
Feb 22, 2016
Formula Pharmaceuticals and Rockland Immunochemicals Enter Into a Collaboration To Develop C.I.K. CAR Immunotherapy Pipeline for the Treatment of Cancer
Aug 3, 2015
Formula Pharmaceuticals and the Max Delbrück Center for Molecular Medicine Enter Into an Exclusive Licensing Agreement and Strategic Collaboration to Develop C.I.K. CAR™ Immunotherapies
May 11, 2015
Formula Pharmaceuticals Acquires Next-Generation, Allogeneic, Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform; Completes Private Fundraising
May 1, 2014
Formula Pharmaceuticals Appoints Dr. Daniel D. Von Hoff as Chairman of the Scientific Advisory Board
Jun 4, 2012
Formula Pharmaceuticals Appoints Morton Collins to Board of Directors
Feb 8, 2012
Formula Pharmaceuticals Appoints Dr. Wolfgang Oster as Chairman, Board of Directors
Jan 24, 2012
Formula Pharmaceuticals Appoints Martyn Greenacre to Board of Directors
